News | Structural Heart | June 29, 2021

Beaumont Performs Rare Tricuspid Transcatheter Valve-in-valve Procedure

Valve experts use catheter method to help 34-year-old Southeast Michigan woman

The balloon inflation to deploy an Edwards Lifesciences Sapien 3 TAVR valve in a failed surgical tricuspid valve. This valve-in-valve (VIV) procedures was performed at Beaumont in a 34-year-old female patient who was determined to be too high of a surgical risk for SAVR.

The balloon inflation to deploy an Edwards Lifesciences Sapien 3 TAVR valve in a failed surgical tricuspid valve. This valve-in-valve (VIV) procedures was performed at Beaumont in a 34-year-old female patient who was determined to be too high of a surgical risk for a second surgical valve replacement.

June 29, 2021 – Cardiologists at Beaumont Health successfully replaced a 34-year-old woman’s tricuspid valve in a rare transcatheter valve-in-valve procedure using a Sapien 3 transcatheter aortic valve. 

“Our experienced structural heart teams at Beaumont Health can step in where others cannot – to save lives or improve the quality of patient’s lives,” said Beaumont interventional cardiologist Joseph Chattahi, M.D., director of the Structural Heart Disease Program at Beaumont Hospital, Dearborn, and a leading expert in catheter-based valve and other cardiac procedures in the region. “It’s a game-changer for our patients.”

Led by Chattahi, the Beaumont Heart Valve Clinic team at Beaumont Hospital, Dearborn, performed the successful procedure on May 4. The patient went home the next day.

Chattahi said the procedure was the patient’s best hope for survival. In 2017, Beaumont Dearborn cardiothoracic surgeon Timothy L. Sell, M.D., replaced the patient’s malfunctioning native tricuspid valve in a successful open-heart surgery. But two years later, a bacterial infection damaged the bioprosthetic valve – a porcine, or pig, biological valve on a metal ring - that was used to replace the native valve. As a result, the patient became very sick starting in 2019 with extreme fatigue, shortness of breath and swelling in her abdomen from the pooling of fluid. She also was at risk of damage to her liver from the potential of fluid backing up into the vessels leading to the vital organ.

“She needed help badly,” said Chattahi. “She was getting progressively worse. It’s not uncommon for doctors to say that nothing else can be done for people with advanced tricuspid valve disease. It can be a difficult valve to access safely, so issues with the tricuspid valve should be treated by very experienced teams.” 

The patient was initially evaluated for another open-heart surgery by Sell. But due to the prior surgery, resulting scar tissue and her clinical condition, another open-heart procedure would be risky.

Chattahi and Sell reviewed her case with other members of the Multidisciplinary Structural Heart Team at Beaumont Hospital, Dearborn, including Samir Dabbous, M.D., director of the cardiac catheterization lab at Beaumont, Dearborn; interventional cardiologist Rita Coram, M.D.; cardiac surgeons Reza Dabir, M.D., and Baron Hamman, M.D.; cardiac imaging specialist Paolo Marciano, M.D., and other experts in catheter-based procedures.

Together, they determined that a novel, catheter-based approach would be the safest method for replacing her malfunctioning tricuspid valve.  The patient was relieved to hear that her heart could be repaired without having to reopen her chest, so she made the decision to move ahead with the procedure by doctors Chattahi, Coram and Sell.

“We are fortunate to have both surgical and catheter-based approaches for patients with advanced cardiac conditions, and we rely on a team approach to determine which option is safest for each patient,” Sell explained. “It is our privilege to work with doctors throughout Beaumont Health and referring physicians across Michigan to provide expert cardiac care and ongoing follow-up with each patient’s own cardiologist. Working together helps us best serve our patients.” 

Planning for the rare procedure began with high-resolution CT scans and 3-D transesophageal echocardiography (TEE). With TEE, cardiac imaging specialists use a small ultrasound probe inserted into the patient’s esophagus to take pictures of the tricuspid valve prior to the procedure. The structural heart cardiologists then use the CT and TEE images to choose a properly sized valve for the patient’s anatomy. 

The procedure took about 40 minutes. A catheter was inserted into a small incision near the patient’s upper thigh and groin area, and was guided through a vessel that travels up the body into the patient’s heart.

The team then inflated a balloon inside the old valve, stretching the diseased leaflets to create more room for the new valve. The Beaumont team then deployed the new valve, a balloon-expandable Edwards Lifescineces Sapien 3 TAVR valve, inside the old valve, which anchors it in place.

“She told us the next day she felt like a new person,” Chattahi said. “We’re so glad she’s feeling better.” 

For more information: www.Beaumont.org/valveclinic

Find more structural heart content

Related Content

Feature | Cath Lab | September 14, 2021 | By Aaron Detate and Lars Thording
In the electrophysiology (EP) lab, hundreds
An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

News | Cath Lab | July 22, 2021
July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of
ast End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company's SafeCross Transseptal Radiofrequency (RF) Puncture and Steerable Balloon Introducer System. The 3-in-1 system, which includes a steerable introducer sheath with an ultra-visible positioning balloon and radiofrequency (RF) puncture dilator, aims to provide a predictable and safe solution for electrophysiology (EP) and structural heart interventions requiring left atrial access.
News | Cath Lab | July 14, 2021
July 13, 2021 — East End Medical announced it received U.S.
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone. #SCAI21 #SCAI2021 Creating a card0-renal program.

There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone.

Feature | Cath Lab | May 14, 2021 | By Dave Fornell, Editor
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal fun
Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting proc

Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.

News | Cath Lab | May 12, 2021
May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has
SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI heart attack. #SCAI21 #SCAI2021

SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI.

Feature | Cath Lab | May 06, 2021 | By Dave Fornell, Editor
April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from
Most Stable Ischemic Heart Disease Patients Did Not Meet ISCHEMIA Trial Enrollment Criteria, raising questions about its application in real-world practice. #SCAI2021 Getty Images

Getty Images

News | Cath Lab | May 03, 2021
May 3, 2021 – Results from a new study find a broad range of patients who typically undergo revascularization for sta
New study demonstrates depression, HIV, mental health, obesity, alcohol and drug abuse are risk factors on most common type of heart disease in young black patients. Photo by Dave Fornell
News | Cath Lab | April 29, 2021
April 29, 2021 – A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American
There are far fewer patients coming to hospitals with heart attacks during the COVID-19 pandemic as compared to averages prior to the pandemic. This has raised concerns that delayed treatment will cause an uptick in cardiac deaths and heart failure. Photo from Getty Images 

There are far fewer patients coming to hospitals with heart attacks during the COVID-19 pandemic as compared to averages prior to the pandemic. This has raised concerns that delayed treatment will cause an uptick in cardiac deaths and heart failure. Photo from Getty Images 

News | Cath Lab | April 28, 2021
April 28, 2021 – Results from a retrospective observational study, presented today at...